{"id":"https://openalex.org/W1994042658","doi":"https://doi.org/10.1517/17460441.2013.788496","title":"Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies","display_name":"Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies","alternate_titles":[],"publication_year":2013,"publication_date":"2013-04-18","ids":{"openalex":"https://openalex.org/W1994042658","doi":"https://doi.org/10.1517/17460441.2013.788496","mag":"1994042658","pmid":"https://pubmed.ncbi.nlm.nih.gov/23594139","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3998639"},"language":"en","primary_location":{"id":"doi:10.1517/17460441.2013.788496","doi":"https://doi.org/10.1517/17460441.2013.788496","is_oa":false,"landing_page_url":"https://doi.org/10.1517/17460441.2013.788496","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994042658"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3998639","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005028213","display_name":"Thomas P. Matthews","orcid":"https://orcid.org/0000-0002-4765-7734","observed_orcids":["https://orcid.org/0000-0002-4765-7734"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas P Matthews","raw_affiliation_strings":["Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit, London SM2 5NG, UK","Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit,\nLondon SM2 5NG, UK +44 0 20 8722 4317"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit, London SM2 5NG, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit,\nLondon SM2 5NG, UK +44 0 20 8722 4317","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021438499","display_name":"Alan M. Jones","orcid":"https://orcid.org/0000-0002-3897-5626","observed_orcids":["https://orcid.org/0000-0002-3897-5626"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan M Jones","raw_affiliation_strings":["Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit, London SM2 5NG, UK +44 0 20 8722 4317; ian.collins@icr.ac.uk","Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit,\nLondon SM2 5NG, UK +44 0 20 8722 4317"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit, London SM2 5NG, UK +44 0 20 8722 4317; ian.collins@icr.ac.uk","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit,\nLondon SM2 5NG, UK +44 0 20 8722 4317","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007384881","display_name":"Ian Collins","orcid":"https://orcid.org/0000-0002-8143-8498","observed_orcids":["https://orcid.org/0000-0002-8143-8498"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Ian Collins","raw_affiliation_strings":["Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit, London SM2 5NG, UK +44 0 20 8722 4317; ian.collins@icr.ac.uk","Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit,\nLondon SM2 5NG, UK +44 0 20 8722 4317"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit, London SM2 5NG, UK +44 0 20 8722 4317; ian.collins@icr.ac.uk","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit,\nLondon SM2 5NG, UK +44 0 20 8722 4317","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007384881"],"corresponding_institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2801316944"],"apc_list":null,"apc_paid":null,"fwci":0.6424,"has_fulltext":false,"cited_by_count":73,"citation_normalized_percentile":{"value":0.52409046,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"8","issue":"6","first_page":"621","last_page":"640"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.37040001153945923,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.37040001153945923,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.21089999377727509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.06719999760389328,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.8479999899864197},{"id":"https://openalex.org/keywords/chk2","display_name":"Chk2","score":1.0},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8830000162124634},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.878000020980835},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.7760000228881836},{"id":"https://openalex.org/keywords/inhibitor-selectivity","display_name":"inhibitor selectivity","score":0.6359999775886536},{"id":"https://openalex.org/keywords/replication-stress","display_name":"replication stress","score":0.781000018119812},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8519999980926514},{"id":"https://openalex.org/keywords/clinical-candidates","display_name":"clinical candidates","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C50001416","wikidata":"https://www.wikidata.org/wiki/Q17861750","display_name":"CHEK1","level":5,"score":0.6064686179161072},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6025872230529785},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5101047158241272},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5055897235870361},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.43612056970596313},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37647783756256104},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.35946890711784363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.323550820350647},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32011520862579346},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26643890142440796},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2403421700000763},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.23022523522377014},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.12462562322616577},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08955049514770508},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07899999618530273},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071877","descriptor_name":"Checkpoint Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D030562","descriptor_name":"Databases, Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064447","descriptor_name":"Checkpoint Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1517/17460441.2013.788496","doi":"https://doi.org/10.1517/17460441.2013.788496","is_oa":false,"landing_page_url":"https://doi.org/10.1517/17460441.2013.788496","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},{"id":"pmid:23594139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23594139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug discovery","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2976101","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3998639","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3998639","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3998639/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Expert Opin Drug Discov","raw_type":"Text"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/0b7df5cd-d9c1-423f-91b5-4439dd1c540b","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/0b7df5cd-d9c1-423f-91b5-4439dd1c540b","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Matthews, T P, Jones, A M & Collins, I 2013, 'Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies', Expert Opinion on Drug Discovery, vol. 8, no. 6, pp. 621-40. https://doi.org/10.1517/17460441.2013.788496","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2976101","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3998639","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1830539922","display_name":null,"funder_award_id":"C309/A11566","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G3601372966","display_name":null,"funder_award_id":"11566","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8172221596","display_name":null,"funder_award_id":"A11566","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":106,"referenced_works":["https://openalex.org/W93208105","https://openalex.org/W1553367038","https://openalex.org/W1964103669","https://openalex.org/W1966534221","https://openalex.org/W1967042600","https://openalex.org/W1968135771","https://openalex.org/W1971367480","https://openalex.org/W1972923939","https://openalex.org/W1973785732","https://openalex.org/W1974788629","https://openalex.org/W1977426520","https://openalex.org/W1979703100","https://openalex.org/W1981232727","https://openalex.org/W1985680998","https://openalex.org/W1990667141","https://openalex.org/W1998756818","https://openalex.org/W2008055481","https://openalex.org/W2008212722","https://openalex.org/W2010117632","https://openalex.org/W2014423292","https://openalex.org/W2015679656","https://openalex.org/W2016426158","https://openalex.org/W2020293198","https://openalex.org/W2020495169","https://openalex.org/W2020714490","https://openalex.org/W2021029768","https://openalex.org/W2030646897","https://openalex.org/W2032337333","https://openalex.org/W2040010227","https://openalex.org/W2041680250","https://openalex.org/W2042316019","https://openalex.org/W2043749332","https://openalex.org/W2045305010","https://openalex.org/W2049451509","https://openalex.org/W2050306845","https://openalex.org/W2050565506","https://openalex.org/W2050678136","https://openalex.org/W2051848610","https://openalex.org/W2054576158","https://openalex.org/W2061304828","https://openalex.org/W2062072203","https://openalex.org/W2067188144","https://openalex.org/W2067614594","https://openalex.org/W2069599636","https://openalex.org/W2072763778","https://openalex.org/W2074566794","https://openalex.org/W2074692995","https://openalex.org/W2074981528","https://openalex.org/W2076324577","https://openalex.org/W2077409669","https://openalex.org/W2080758225","https://openalex.org/W2089190410","https://openalex.org/W2090658325","https://openalex.org/W2095986441","https://openalex.org/W2100956291","https://openalex.org/W2101813858","https://openalex.org/W2102815568","https://openalex.org/W2104357345","https://openalex.org/W2105979581","https://openalex.org/W2106844715","https://openalex.org/W2108700206","https://openalex.org/W2109554640","https://openalex.org/W2115028228","https://openalex.org/W2115875682","https://openalex.org/W2117355601","https://openalex.org/W2117389132","https://openalex.org/W2117692326","https://openalex.org/W2118023637","https://openalex.org/W2125026963","https://openalex.org/W2125205880","https://openalex.org/W2131592745","https://openalex.org/W2132254460","https://openalex.org/W2133150002","https://openalex.org/W2134647795","https://openalex.org/W2135946515","https://openalex.org/W2137108719","https://openalex.org/W2139291133","https://openalex.org/W2140990686","https://openalex.org/W2141140503","https://openalex.org/W2141444873","https://openalex.org/W2143008443","https://openalex.org/W2145264022","https://openalex.org/W2146998614","https://openalex.org/W2148362722","https://openalex.org/W2148958834","https://openalex.org/W2149590746","https://openalex.org/W2151918127","https://openalex.org/W2153812820","https://openalex.org/W2155071772","https://openalex.org/W2155205362","https://openalex.org/W2155390225","https://openalex.org/W2162730779","https://openalex.org/W2164905805","https://openalex.org/W2169622674","https://openalex.org/W2173120688","https://openalex.org/W2191018771","https://openalex.org/W2263432340","https://openalex.org/W2313623119","https://openalex.org/W2321977755","https://openalex.org/W2324276975","https://openalex.org/W2326728180","https://openalex.org/W2327485242","https://openalex.org/W2416730013","https://openalex.org/W2471074091","https://openalex.org/W2591551942","https://openalex.org/W4246239285"],"related_works":["https://openalex.org/W2008055481","https://openalex.org/W2148362722","https://openalex.org/W2067614594","https://openalex.org/W2416730013","https://openalex.org/W4205166053","https://openalex.org/W3016116078","https://openalex.org/W2804858811","https://openalex.org/W1980010870","https://openalex.org/W4413295183","https://openalex.org/W1973785732"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Checkpoint":[1],"kinase":[2],"(CHK)":[3],"inhibitors":[4,137,153,159,189],"offer":[5],"the":[6,10,21,28,42,54,63,66,74,79,82,85,100,149,171,180,203],"promise":[7],"of":[8,12,58,68,76,84,130,135,151,182,206],"enhancing":[9],"effectiveness":[11],"widely":[13],"prescribed":[14],"cancer":[15],"chemotherapies":[16],"and":[17,46,56,89,96,167],"radiotherapy":[18],"by":[19],"inhibiting":[20],"DNA":[22],"damage":[23],"response,":[24],"as":[25,27],"well":[26],"potential":[29,205],"for":[30,94,102,125,175,187],"single":[31,103,183],"agent":[32,104,184],"efficacy.":[33,105],"AREAS":[34],"COVERED:":[35],"This":[36],"article":[37],"surveys":[38],"structural":[39,115],"insights":[40],"into":[41],"checkpoint":[43,136],"kinases":[44],"CHK1":[45,95,152,158,188],"CHK2":[47,97,176],"that":[48,117],"have":[49,138],"been":[50,139,145],"exploited":[51],"to":[52,72,121,162],"enhance":[53],"selectivity":[55,124,166],"potency":[57],"small":[59],"molecule":[60],"inhibitors.":[61,77],"Furthermore,":[62],"authors":[64,80],"review":[65],"use":[67],"mechanistic":[69],"cellular":[70],"assays":[71],"guide":[73],"optimisation":[75],"Finally,":[78],"discuss":[81],"status":[83],"current":[86],"clinical":[87,92,133],"candidates":[88],"emerging":[90],"new":[91],"contexts":[93],"inhibitors,":[98],"including":[99],"prospects":[101],"EXPERT":[106],"OPINION:":[107],"Protein-bound":[108],"water":[109],"molecules":[110],"play":[111],"key":[112],"roles":[113],"in":[114,147,190,201],"features":[116],"can":[118],"be":[119],"targeted":[120],"gain":[122],"high":[123],"either":[126],"enzyme.":[127],"The":[128],"results":[129],"early":[131],"phase":[132],"trials":[134],"mixed,":[140],"but":[141],"significant":[142],"progress":[143,200],"has":[144],"made":[146],"testing":[148],"combination":[150],"with":[154],"genotoxic":[155],"chemotherapy.":[156],"Second-generation":[157],"are":[160],"likely":[161],"benefit":[163],"from":[164],"increased":[165],"oral":[168],"bioavailability.":[169],"While":[170],"optimum":[172],"therapeutic":[173,204],"context":[174],"inhibition":[177],"remains":[178],"unclear,":[179],"emergence":[181],"preclinical":[185],"efficacy":[186],"specific":[191],"tumour":[192],"types":[193],"exhibiting":[194],"constitutive":[195],"replication":[196],"stress":[197],"represents":[198],"exciting":[199],"exploring":[202],"these":[207],"agents.":[208]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994042658","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
